Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Carbidopa-Levodopa Treatment Report
What is Carbidopa-Levodopa?

Levodopa is a dopamine precursor used to treat the movement disorder symptoms of Parkinson's disease. Carbidopa is often included with levodopa-containing drugs in order to boost its efficacy by slowing down the metabolism of dopamine.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
To control Parkinsonian traits 1 0
Other 1 1
twitches and jerks 1 1
Stiffness/Spasticity 1 0
Mobility 1 0
Balance problems 1 1

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 50%
None
1 50%

Most commonly reported side effects

Vivid dreams
1 50%
Drowsiness
1 50%
Dizziness
1 50%
  • Mild
  • Moderate
  • Severe

Dosages

  25 mg-100 mg daily 2 x 25 mg-100 mg daily 300 mg daily 3 x 25 mg-100 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Carbidopa-Levodopa (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 100% Did not seem to work: 100%
Doctor's advice
1 100% Doctor's advice: 100%

See all 1 patient who’ve stopped taking Carbidopa-Levodopa

Currently Taking Carbidopa-Levodopa

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
1
0
1
1

Stopped Taking Carbidopa-Levodopa

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 50%
Usually
1 50%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 50%
Not at all
1 50%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.